Heartlung Technologies To Launch Autochambertm AI At ACC 2025 And Begin Offering The AI ...
HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamberTM) at ACC 2025, offering lifesaving AI solutions for CVD prevention. Marlon Montes HeartLung Corporation +1 ...
Renal & Urology News10 小时
Study IDs Post-Transplant Anemia Contributors, Clarifies Role of ESAs
A systematic review and meta-analysis identified factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents (ESAs).
Heartlung Technologies Selected As A Finalist For ACC 2025 Innovation Pitch Challenge
HeartLung Technologies selected as a finalist and will compete at the ACC 2025 Innovation Pitch Challenge in Chicago. Marlon Montes HeartLung Corporation +1 310-510-6004 ... Visit us on social media: ...